CoChat

Benchmarking biomarker‐based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem

Rosén, Christoffer, Farahmand, Bahman, Skillbäck, Tobias, Nägga, Katarina, Mattsson, Niklas, Kilander, Lena, Religa, Dorota, Wimo, Anders, Blennow, Kaj, Winblad, Bengt, Zetterberg, Henrik, Eriksdotter, Maria · 2015 · Alzheimer's & Dementia
Cited by 20

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Introduction: New research guidelines for the diagnosis of Alzheimer's disease (AD) include biomarker evidence of amyloid‐β (Aβ) and tau pathology. The aim of this study was to investigate what proportion of AD patients diagnosed in clinical routine in Sweden that had an AD‐indicative cerebrospinal fluid (CSF) biomarker profile. Methods: By cross‐referencing a laboratory database with the Swedish Dementia Registry (SveDem), 2357 patients with data on CSF Aβ and tau biomarkers and a clinical diagnosis of AD with dementia were acquired. Results: Altogether, 77.2% had pathologic Aβ 42 and total tau or phosphorylated tau in CSF. These results were stable across age groups. Female sex and low mini‐mental state examination score increased the likelihood of pathologic biomarkers. Discussion: About a quarter of clinically diagnosed AD patients did not have an AD‐indicative CSF biomarker profile. This discrepancy may partly reflect incorrect (false positive) clinical diagnosis or a lack in sensitivity of the biomarker assays.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2015.04.007

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 20

Metadata

Authors
Rosén, C., Farahmand, B., Skillbäck, T., Nägga, K., Mattsson, N., Kilander, L., Religa, D., Wimo, A., Blennow, K., Winblad, B., Zetterberg, H., & Eriksdotter, M.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2015-06-13
Volume
11
Issue
12
Pages
1470-1479
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W1891261562
Cited by
20
References
12
FWCI
1.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benchmarking biomarker‐based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem. https://app.cochat.ai/papers/10.1016/j.jalz.2015.04.007
The paper
Rosén, C., Farahmand, B., Skillbäck, T., Nägga, K., Mattsson, N., Kilander, L., Religa, D., Wimo, A., Blennow, K., Winblad, B., Zetterberg, H., & Eriksdotter, M. (2015). Benchmarking biomarker‐based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2015.04.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.